Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

585
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
585
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

468
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
468
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

459
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
459
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

1.1K
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
1.1K
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

1.3K
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.3K
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

811
Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
811

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Expert perspectives on de-escalation of antiplatelet therapy - Beyond the guidelines: Insights from the cardiovascular research technologies 2026 meeting.

Cardiovascular revascularization medicine : including molecular interventionsยท2026
Same author

Does Height Influence the Effectiveness of Beta-Blocker Therapy after Myocardial Infarction?

Cardiologyยท2026
Same author

Investigation of Possible Cardiac Manifestations of Dysautonomia in a Patient With Acquired Ondine's Curse Syndrome: A Rare Clinical Case Report.

Cureusยท2026
Same author

Editorial: Epicardial-only left atrial appendage closure: Insights from seven years of first-in-human experience.

Cardiovascular revascularization medicine : including molecular interventionsยท2026
Same author

Editorial: Do we still need routine pre-discharge echocardiography after LAAC?

Cardiovascular revascularization medicine : including molecular interventionsยท2026
Same author

Cardio-oncology Outcomes in Ultrasound-assisted Versus Standard Catheter-directed Thrombolysis for Acute Pulmonary Embolus.

Journal of the Society for Cardiovascular Angiography & Interventionsยท2025

Related Experiment Video

Updated: Apr 3, 2026

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

4.6K

Time to Expand the Mitra-Clip Indications.

Konstantinos Marmagkiolis1,2, Mehmet Cilingiroglu3,4

  • 1Citizens Memorial Heart and Vascular Institute, Bolivar, MO.

Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|September 20, 2015
PubMed
Summary

MitraClip implantation shows low in-hospital major adverse cardiovascular and cerebrovascular events (MACCE) in high-risk patients. However, bleeding and vascular complications necessitate further research into device improvements and patient selection for optimal outcomes.

More Related Videos

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

2.8K
Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
08:42

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

4.5K

Related Experiment Videos

Last Updated: Apr 3, 2026

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

4.6K
Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

2.8K
Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
08:42

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

4.5K

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology

Background:

  • The MitraClip device offers a minimally invasive option for treating mitral regurgitation, particularly in patients deemed high-risk for traditional surgery.
  • Assessing the safety and efficacy of MitraClip implantation is crucial for managing complex cardiac conditions.

Discussion:

  • MitraClip implantation demonstrates a favorable safety profile with low rates of in-patient major adverse cardiovascular and cerebrovascular events (MACCE), even in high-risk populations.
  • Bleeding and vascular complications are identified as the primary procedural risks associated with MitraClip implantation.

Key Insights:

  • The procedure is effective in reducing MACCE for high-risk individuals.
  • Procedural complications are predominantly bleeding and vascular issues.

Outlook:

  • Future research should focus on developing smaller caliber MitraClip devices to minimize vascular access complications.
  • Investigating alternative access techniques and refining patient selection criteria are essential for further optimizing procedural safety and outcomes.